Cheav Sotheara sold $784K of ACMR
Cheav Sotheara (See remarks) sold 9,212 shares of ACM Research, Inc. (ACMR) at $85.11 ($0.78M total) on 2026-06-04 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
Given the pre-arranged nature and lack of new fundamentals, the trading impact is likely limited to short-term sentiment.
Market read
Routine insider sale disclosure; not a new catalyst for ACMR.
What to watch
The disclosure does not reveal whether the sale was part of a larger multi-tranche program or whether other insiders simultaneously bought/sold.
Background
SEC Form 4 reports insider transactions; a 10b5-1 plan means trades were pre-scheduled under SEC rules.
Ticker impact
ACMR officer Cheav Sotheara sold 9,212 shares in an open-market transaction under a pre-arranged 10b5-1 plan.
Low likelihood of a sustained price move; any reaction is likely brief and sentiment-driven.
The filing is a routine Form 4 with a stated 10b5-1 plan, and it provides no new company-specific operational or financial information.
Market effects
No clear sector read-through from a single 10b5-1 insider sale.
None indicated.
None indicated.
Counterpoint
Even with a 10b5-1 plan, repeated insider selling can coincide with periods of valuation or liquidity-driven selling pressure.
Key entities
- issuerACM Research, Inc.
Company whose officer disclosed an open-market sale of shares under a 10b5-1 plan.
- insiderCheav Sotheara
Officer who sold 9,212 shares at $85.1100/share on 2026-06-04.
